# Cohance Lifesciences shares rise despite weak first-quarter results 2026-08-06T07:19:43+00:00 | Business & Economy | Indian Opinion Desk Shares in Cohance Lifesciences rose more than 2% even after the company reported a weak June quarter, with a net loss of Rs 24.1 crore against a year-earlier profit of Rs 48.9 crore, as revenue fell 23.1% to Rs 422 crore and EBITDA plunged 99% to Rs 1.2 crore, according to NDTV Profit. Investors appeared to focus on a US Food and Drug Administration inspection of the company's Pashamylaram plant in Hyderabad, which closed with a Form FDA 483 citing five observations, none related to data integrity, an outcome seen as reassuring given the stock's roughly 53% decline over the past year. Cohance said it is assessing the observations and will submit a corrective response within the prescribed timeline. The report does not specify what the five observations concern beyond confirming none involve data integrity. ## Indian Opinion Analysis The scale of the quarterly decline, a swing from profit to loss alongside a 99% collapse in EBITDA, is severe by any measure, which makes the market's muted reaction notable. The absence of data-integrity findings in this one inspection removes a specific, serious regulatory risk, but the five observations still need a corrective response, and the report does not say how significant they otherwise are. Investors may be pricing in relief rather than a turnaround, since the underlying business weakened sharply this quarter. Cohance's corrective response to the FDA observations, and its next quarterly results, will show whether this relief holds. ## Coverage - www.ndtvprofit.com Tags: Cohance Lifesciences, NDTV Profit Canonical: https://indianopinion.org/cohance-lifesciences-stock-jumps-over-2-despite-poor-q1-earnings-heres-why/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/cohance-lifesciences-stock-jumps-over-2-despite-poor-q1-earnings-heres-why/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.